欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0791/001
药品名称Levobens-TEVA 50 mg/ 12,5 mg Hartkaspeln
活性成分
    • benserazide hydrochloride 12.5 mg
    • levodopa 50.0 mg
剂型Capsule, hard
上市许可持有人TEVA GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
      Levodopa/Benserazide 50/12.5 PCH, capsules 50/12.5 mg
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
许可日期2007/10/18
最近更新日期2024/04/17
药物ATC编码
    • N04BA02 levodopa and decarboxylase inhibitor
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase